Iṣowo ọja, iṣowo owo loni
Awọn abajade iṣura ti awọn ile-iṣẹ 71229 ni akoko gidi.
Iṣowo ọja, iṣowo owo loni

Awọn abajade iṣura

Awọn abajade iṣowo lori ayelujara

Awọn iṣeduro awọn iṣan itan

Iṣowo capital market

Awọn ipinpin owo iṣura

Èrè lati ile-iṣẹ ile-iṣẹ

Iroyin owo

Awọn ifowo iyasọtọ ti ile-iṣẹ. Nibo lati gbewo owo?

Adaptimmune Therapeutics plc oja fila

Iwọn didun iṣowo ọja Adaptimmune Therapeutics plc loni ati itan itan-iṣowo ti Adaptimmune Therapeutics plc lati ibẹrẹ iṣowo ni ADAP ṣe alabapin lori iyipada ọja.
Fi kun ẹrọ ailorukọ
Fi kun si awọn ẹrọ ailorukọ

Adaptimmune Therapeutics plc capitalization

Loni onipaarọ iṣowo ti Adaptimmune Therapeutics plc jẹ 234 468 320 US dollar.
+7 456 576 $ (+3.28%)
iyipada ti iṣiparọ-pupọ niwon oṣu

Adaptimmune Therapeutics plc ipin-iṣẹ ni awọn dọla loni. Lojoojumọ, a ṣe igbasilẹ ayipada kan ni Adaptimmune Therapeutics plc kapitolu. Apapọ gbogbo Adaptimmune Therapeutics plc awọn agbasọ ọja iṣura ti oniṣowo loni ni afọwọkọ ti Adaptimmune Therapeutics plc agbasọ ọja. Adaptimmune Therapeutics plc fila fila loni dogba si 234 468 320 Awọn dọla AMẸRIKA.

Adaptimmune Therapeutics plc iwọn didun ti iṣowo

Loni oni iwọn iṣowo ti Adaptimmune Therapeutics plc jẹ 302 744 US dollar.
-37 303 $ (-10.97%)
iyipada iwọn didun ti iṣowo lati igba atijọ

Adaptimmune Therapeutics plc awọn ipele iṣowo loni = 302 744 Awọn dọla AMẸRIKA. Adaptimmune Therapeutics plc ti ta lori awọn paṣiparọ iṣura ọja oriṣiriṣi. Adaptimmune Therapeutics plc iṣowo ni akoko gidi ti o waye lori awọn paṣipaarọ agbasọ ọja julọ, oju opo wẹẹbu wa ṣafihan iwọn iṣowo ojoojumọ ti Adaptimmune Therapeutics plc. Iye gbogbo wọn Adaptimmune Therapeutics plc awọn akojopo ti oniṣowo (p. Adaptimmune Therapeutics plc oja fila) pọ si nipasẹ $ 7 456 576.

Fihan:
To

Adaptimmune Therapeutics plc koja apẹrẹ chart

Adaptimmune Therapeutics plc ọja kapusulu ọja lori iwọn lori awọn ọdun. Ni ọsẹ kan, Adaptimmune Therapeutics plc gbigbe kapitolu ti yipada nipasẹ 6.39%. Ni ọdun, Adaptimmune Therapeutics plc gbigbe kapitolu ti yipada nipasẹ 0%. Loni, Adaptimmune Therapeutics plc gbigbe kaakiri dogba si 234 468 320 Awọn dọla AMẸRIKA.

Osu Oṣu 3 osu Odun 3 ọdun

Adaptimmune Therapeutics plc itan akọọlẹ

Ọjọ Ipilẹ agbara
Ipilẹ-iṣowo (iṣowo pataki oja) jẹ iye owo tita gbogbo awọn ile-iṣẹ ti awọn ile-iṣowo ti o ta lori iṣowo ọja. Ipilẹ agbara oja jẹ iwongba ti iye owo awọn iyipo ti o pọ nipasẹ nọmba ti awọn ọja ti o ni iyasọtọ.
03/05/2023 234 468 320 $
02/05/2023 227 011 744 $
01/05/2023 238 610 896 $
28/04/2023 227 011 744 $
27/04/2023 231 154 288 $
26/04/2023 227 011 744 $
25/04/2023 220 383 664 $

Adaptimmune Therapeutics plc iwọn iwe iwọn didun

Osu Oṣu 3 osu Odun 3 ọdun

Adaptimmune Therapeutics plc iwọn itan itan-itan

Ọjọ Iwọn didun (24h)
Iwọn iṣowo iṣowo ti Adaptimmune Therapeutics plc iyatọ ni iye ti gbogbo awọn iṣowo pẹlu awọn ADAP mọlẹbi ti ra ati ta ni ọjọ ti a yan.
03/05/2023 302 744 $
02/05/2023 340 047 $
01/05/2023 241 044 $
28/04/2023 80 435 $
27/04/2023 245 476 $
26/04/2023 82 552 $
25/04/2023 641 172 $

03/05/2023 Adaptimmune Therapeutics plc kapitalisimu ọja jẹ dogba si 234 468 320 Awọn dọla AMẸRIKA. Adaptimmune Therapeutics plc kapitalisimu ọja jẹ $ 227 011 744 ni 02/05/2023. 01/05/2023 Adaptimmune Therapeutics plc kapitalisimu ọja jẹ dogba si 238 610 896 Awọn dọla AMẸRIKA. Adaptimmune Therapeutics plc ikowe ni 28/04/2023 jẹ dogba si 227 011 744 Awọn dọla AMẸRIKA.

Iṣiro ọja ti Adaptimmune Therapeutics plc ni 27/04/2023 ti o jẹ si 231 154 288 awọn dọla AMẸRIKA. 26/04/2023 Adaptimmune Therapeutics plc kapitalisimu ọja jẹ dogba si 227 011 744 Awọn dọla AMẸRIKA. 25/04/2023 Adaptimmune Therapeutics plc kapitalisimu dogba si 220 383 664 Awọn dọla AMẸRIKA.

Awọn capitalitalization ti Adaptimmune Therapeutics plc loni ni 234 468 320 $. Awọn capitalization oja ti Adaptimmune Therapeutics plc ti yi pada si +3.28% akawe pẹlu lana. Iwọn iṣowo iṣowo ti ADAP ti Adaptimmune Therapeutics plc ni ọjọ iṣowo to koja ni 302 744 $. Iwọn iṣowo ti awọn ipinlẹ ti Adaptimmune Therapeutics plc yipada si -10.97% ti akawe si ọjọ iṣowo iṣaaju.

Awọn iye owo ti awọn mọlẹbi Adaptimmune Therapeutics plc

Isuna Adaptimmune Therapeutics plc